header advert
Results 1 - 1 of 1
Results per page:
Applied filters
Research
Include Proceedings
Access
Journals
Abstracts
Dates
Year From
Year To
Specialties
Orthopaedic Proceedings
Vol. 96-B, Issue SUPP_11 | Pages 304 - 304
1 Jul 2014
A BLINDED, MULTI-CENTRE, CLINICAL AND RADIOLOGICAL STUDY TO EVALUATE THE EFFICACY OF OSTEOAMP VERSUS RHBMP-2 IN TLIF/LLIF PROCEDURES
Roh J Yeung C Field J
Full Access
View article

Summary

In this study, OsteoAMP® bone graft showed superior fusion rates as compared to rhBMP-2 at all timepoints (p<0.004). Additionally, OsteoAMP® bone graft had >80% few adverse events as compared to rhBMP-2.

Introduction

Adverse events and complications related to use of rhBMP-2 have raised many ethical, legal, and reimbursement concerns for surgeons. OsteoAMP® bone graft is an allograft derived growth factor, rich in osteoinductive, angiogenic, and mitogenic proteins. The following data displays a blinded, multi -center study evaluating and comparing fusion outcomes between rhBMP-2 and OsteoAMP® bone graft.